Candinas D et al. |
Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7527959
|
|
Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK506-based immunosuppression. European FK506 Multicentre Liver Study Group. |
1994 |
Transplant. Proc. |
pmid:7527960
|
Alessiani M et al. |
Adverse effects of FK 506 overdosage after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7679825
|
Nishikawa K et al. |
Experimental studies of vascularized joint allografts in rats. |
1994 |
Transplant. Proc. |
pmid:7513482
|
Lye WC |
Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience. |
2000 |
Transplant. Proc. |
pmid:11119898
|
Klintmalm GB et al. |
Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. |
1993 |
Transplant. Proc. |
pmid:7679826
|
Fukuzawa M and Okada A |
Analysis of mouse xenogeneic T-cell responses and the effect of FK 506 on these responses and on xeno-skin graft rejection. |
1994 |
Transplant. Proc. |
pmid:7513483
|
Warty VS et al. |
Practical aspects of FK 506 analysis (Pittsburgh experience). |
1991 |
Transplant. Proc. |
pmid:1721259
|
Bechstein WO et al. |
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623211
|
Sher LS et al. |
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623212
|
Yamamoto S et al. |
FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808570
|
Alessiani M et al. |
Infections with FK 506 immunosuppression: preliminary results with primary therapy. |
1990 |
Transplant. Proc. |
pmid:1689895
|
Ben-Ari Z et al. |
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12644067
|
Sugioka A et al. |
FK 506 inhibits tolerance induction in mice liver transplantation. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808576
|
Lladó L et al. |
Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation. |
2002 |
Transplant. Proc. |
pmid:11959210
|
Chang HY et al. |
Long-term follow-up of arrhythmia characteristics and clinical outcomes in heart transplant patients. |
2013 Jan-Feb |
Transplant. Proc. |
pmid:23375324
|
Taibi A et al. |
Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases. |
1998 |
Transplant. Proc. |
pmid:9636571
|
Melo MJ et al. |
Impact of conversion from Advagraf to twice-daily generic tacrolimus in kidney transplant recipients: a single-center study. |
2015 |
Transplant. Proc. |
pmid:26036484
|
Müller H et al. |
Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: preliminary report in Chile. |
2008 |
Transplant. Proc. |
pmid:18454992
|
Oishi M et al. |
A case of hyperkalemic distal renal tubular acidosis secondary to tacrolimus in living donor liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11120143
|
Lo CM et al. |
More effective immunosuppression with the use of FK506 after liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11120161
|
Soriano S et al. |
Single-center experience with initial intravenous dosing of tacrolimus after kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10576045
|
van Hooff JP et al. |
Dosing and management guidelines for tacrolimus in renal transplant patients. |
1999 |
Transplant. Proc. |
pmid:10576046
|
Hu RH et al. |
Effects of and predictors for tacrolimus rescue therapy among renal transplant patients under cyclosporine-based immunosuppression. |
2004 |
Transplant. Proc. |
pmid:15518757
|
McLachlan G et al. |
Growth inhibition of the MOLT-4 human T-leukemia cell line. A comparison of cyclosporine and FK 506. |
1991 |
Transplant. Proc. |
pmid:1721291
|
Akselband Y et al. |
Rapamycin inhibits spontaneous and fibroblast growth factor beta-stimulated proliferation of endothelial cells and fibroblasts. |
1991 |
Transplant. Proc. |
pmid:1721292
|
D'Silva M et al. |
Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623476
|
Klintmalm GB |
Clinical use of FK 506 in liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623484
|
Colak H et al. |
Relationship of Interleukin-10 and Transforming Growth Factor-β Levels With Short-Term Graft Function After Kidney Transplantation. |
2015 |
Transplant. Proc. |
pmid:25964218
|
Goulet O et al. |
Small bowel transplantation alone or with the liver in children: changes by using FK506. |
1998 |
Transplant. Proc. |
pmid:9636636
|
Zhao J et al. |
Diabetes mellitus after living donor liver transplantation: data from mainland China. |
2009 |
Transplant. Proc. |
pmid:19545722
|
Kliem V et al. |
Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients. |
1997 |
Transplant. Proc. |
pmid:9365627
|
Fujisaki S et al. |
Effects of preformed antibodies induced by whole blood transfusion on small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518140
|
Teisseyre J et al. |
Elevated tacrolimus levels during diarrhea in children after liver transplantation. |
2003 |
Transplant. Proc. |
pmid:14529919
|
Jacob DA et al. |
Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. |
2005 |
Transplant. Proc. |
pmid:15919432
|
Junge G et al. |
Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitis. |
2005 |
Transplant. Proc. |
pmid:15919434
|
Tze WJ et al. |
FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats. |
1992 |
Transplant. Proc. |
pmid:1376509
|
Rao PN et al. |
Prediction of early graft function by effluent levels of hyaluronic acid in clinical liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7682366
|
Armstrong VW et al. |
Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine. |
1995 |
Transplant. Proc. |
pmid:7533371
|
Takai K et al. |
Delayed graft function after renal transplantation from a non-heart-beating donors. |
2003 |
Transplant. Proc. |
pmid:12591320
|
Ushigome H et al. |
Pediatric living-related renal transplantation under tacrolimus as the primary immunosuppressive agent. |
2003 |
Transplant. Proc. |
pmid:12591350
|
Jordan ML et al. |
Inhibition of T-cell function by FK 506 and cyclosporine is not accompanied by alterations in intracellular calcium. |
1991 |
Transplant. Proc. |
pmid:1721323
|
Mayer AD |
Chronic rejection and graft half-life: five-year follow-up of the European Tacrolimus Multicenter Renal Study. |
2002 |
Transplant. Proc. |
pmid:12176452
|
Daly I et al. |
Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus. |
2002 |
Transplant. Proc. |
pmid:12176458
|
Esposito C et al. |
Effect of calcineurin inhibitors on extracellular matrix turnover in isolated human glomeruli. |
2004 |
Transplant. Proc. |
pmid:15110634
|
Wlodarczyk Z et al. |
Lipid metabolism in renal transplant patients receiving tacrolimus/sirolimus combination therapy. |
2005 |
Transplant. Proc. |
pmid:15919489
|
Funayama Y et al. |
Changes in cell adhesion molecules after small bowel transplantation in rats. |
1995 |
Transplant. Proc. |
pmid:7533426
|
Laskow DA et al. |
Phase II FK 506 multicenter concentration control study: one-year follow-up. |
1995 |
Transplant. Proc. |
pmid:7533431
|
Paul AA et al. |
CMV retinitis and the use of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721354
|
Reyes J et al. |
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721355
|
Pape L et al. |
Long-term stable glomerular filtration rate achieved with tacrolimus in pediatric renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12270367
|
van Hooff JP et al. |
Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results. |
2002 |
Transplant. Proc. |
pmid:12176498
|
Wu MS et al. |
Cyclosporine, but not FK 506 and rapamycin, enhances cell proliferation in mouse medullary thick ascending cultured cells. |
1998 |
Transplant. Proc. |
pmid:9838561
|
Cheng CY et al. |
Intervention of Online Percent Coefficient of Variation Reporting System Reduces the Variability of Tacrolimus Trough Concentration in Kidney Transplant Recipients. |
2018 |
Transplant. Proc. |
pmid:30316366
|
Meiser BM et al. |
The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083018
|
Liu Y et al. |
Delayed Initiation of Tacrolimus Is Safe and Effective in Renal Transplant Recipients With Delayed and Slow Graft Function. |
2018 |
Transplant. Proc. |
pmid:30316359
|
Platz KP et al. |
Impact of immunosuppression and acute rejection on hepatitis B recurrence. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123107
|
Reyes J et al. |
Intestinal transplantation in children: five-year experience. |
1996 |
Transplant. Proc. |
pmid:8908042
|
Okano K et al. |
Ameliorative effect of FK 506 on cold ischemia reperfusion injury of the rat liver. |
1994 |
Transplant. Proc. |
pmid:7520635
|
Thomson AW et al. |
Immunosuppressive activity, T-cell subset analysis, and acute toxicity of FK-506 in rats. |
1989 |
Transplant. Proc. |
pmid:2468203
|
Hossein-Nia M et al. |
Urinary proteins as a marker of drug-induced renal damage following treatment with cyclosporine or FK 506. |
1991 |
Transplant. Proc. |
pmid:1721388
|
Citterio F et al. |
Steroid withdrawal from tacrolimus-based therapy in renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176545
|
Baran DA et al. |
Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning. |
2002 |
Transplant. Proc. |
pmid:12176547
|
Steinmueller T et al. |
The effect of cyclosporine vs FK 506 on glucose metabolism. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083504
|
Shapiro R et al. |
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083507
|
Fang YH et al. |
AEB-071 versus tacrolimus monotherapy to prevent acute cardiac allograft rejection in the rat: a preliminary report. |
2010 |
Transplant. Proc. |
pmid:20430219
|
Ali IH et al. |
Incidence and risk factors for post-renal transplant diabetes mellitus. |
2011 |
Transplant. Proc. |
pmid:21440763
|
Iacona I et al. |
Mycophenolic acid in combination with FK 506: a pharmacokinetic study in piglets after small-bowel transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123489
|
Ayar Y et al. |
Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience. |
2017 |
Transplant. Proc. |
pmid:28219583
|
Batten P et al. |
Effect of cyclosporine A and FK 506 on human T cell responses to xenogeneic and allogeneic endothelium: relative resistance of T cell/porcine endothelial interactions. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123582
|
Langer RM et al. |
De novo tumors after kidney transplantation: the Budapest experience. |
2003 |
Transplant. Proc. |
pmid:12826170
|
Yamanaka K et al. |
Induction Immunosuppressive Therapy With Everolimus and Low-Dose Tacrolimus Extended-Release Preserves Good Renal Function at 1Â Year After Kidney Transplantation. |
2016 |
Transplant. Proc. |
pmid:27234735
|
Markus PM et al. |
The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721418
|
Yuzawa K et al. |
Topical immunosuppression in skin grafting with FK 506 ointment. |
1996 |
Transplant. Proc. |
pmid:8658707
|
White SA et al. |
Randomized trial comparing neoral and tacrolimus immunousuppression for recipients of renal transplants procured from different donor groups. |
2000 |
Transplant. Proc. |
pmid:10812132
|
Calne RY |
The development of immunosuppression: the rapamycin milestone. |
2003 |
Transplant. Proc. |
pmid:12742463
|
Beckebaum S et al. |
Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study. |
2004 |
Transplant. Proc. |
pmid:15621120
|
Kamar N et al. |
Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C. |
2004 |
Transplant. Proc. |
pmid:15621141
|
Woeste G et al. |
Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study. |
2002 |
Transplant. Proc. |
pmid:12176629
|
Shishido S et al. |
Pharmacokinetics of tacrolimus in pediatric renal transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267193
|
Atillasoy E et al. |
Cholesterol levels long-term after liver transplant. |
1998 |
Transplant. Proc. |
pmid:9723387
|
Quijano Y et al. |
Tolerance: a study in long-term surviving animals after small bowel transplantation. |
1998 |
Transplant. Proc. |
pmid:9745494
|
Kohnle M et al. |
Conversion to tacrolimus in cyclosporin A treated patients with gum hyperplasia. |
1998 |
Transplant. Proc. |
pmid:9723413
|
Alessiani M et al. |
Effect of perioperative donor bone marrow infusion after small bowel transplantation in swine: preliminary results. |
1998 |
Transplant. Proc. |
pmid:9745496
|
Duzova A et al. |
Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year. |
2003 |
Transplant. Proc. |
pmid:14697926
|
Ybarra J et al. |
Reflex sympathetic dystrophy syndrome in renal transplanted patients under immunosuppression with tacrolimus. |
2003 |
Transplant. Proc. |
pmid:14697943
|
Yumiba T et al. |
Immunosuppressive and diabetogenic effect of FK 506 on pancreatic islet xenotransplantation. |
1995 |
Transplant. Proc. |
pmid:7540780
|
Nikolaidis NL et al. |
Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases. |
1991 |
Transplant. Proc. |
pmid:1721450
|
Abu-Elmagd K et al. |
Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. |
1991 |
Transplant. Proc. |
pmid:1721451
|
Ochiai T et al. |
Studies on FK506 in experimental organ transplantation. |
1988 |
Transplant. Proc. |
pmid:2450414
|
Kiji T et al. |
Relationship between immunological rejection and matrix GLA protein in cryopreserved vascular allografts. |
2004 |
Transplant. Proc. |
pmid:15561265
|
|
Immunosuppression: FK506. |
1988 |
Transplant. Proc. |
pmid:2450415
|
Fung JJ et al. |
Current status of FK 506 in liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1712133
|
Mehra MR et al. |
A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267438
|
Yoshimura N et al. |
Development of a macromolecular prodrug of FK 506: III: In vivo disposition of FK 506-dextran conjugate. |
1998 |
Transplant. Proc. |
pmid:9636415
|
Fung JJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. |
1991 |
Transplant. Proc. |
pmid:1703682
|
Boggi U et al. |
Use of basiliximab in conjunction with either Neora/MMF/steroids or Prograf/MMF/steroids in simultaneous pancreas-kidney transplantation. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750373
|
Lawen J et al. |
Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750382
|
Kliem V et al. |
Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients. |
1998 |
Transplant. Proc. |
pmid:9636509
|
Copley JB et al. |
Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts. |
1998 |
Transplant. Proc. |
pmid:9636510
|